www.easilymeds2.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Candesartan - Atacand, Atacand Hct
Generic Atacand
Generic Atacand is used for treating high blood pressure. It may also be used to treat heart failure in certain patients.
$0.64
Buy now!
Generic Atacand Hct
Candesartan Hydrochlorothiazide 8mg + 12.5mg
Generic Atacand HCT is a combination medication used in the treatment of high blood pressure.
$1.02
Buy now!
Choose Your language:
- Testimonials
-
I though the soft tabs would be strips that melted under your tongue. They are as you know just as hard as hard cialis however dissolve under the tongue in about 20 mins. The flavor is fine. Thanks for getting back to me, - Alan
Read more »
-
- Zentiva adds candesartan - Dispensing Doctors' Association
- Zentiva adds candesartanDispensing Doctors' AssociationBy Ailsa Colquhoun Candesartan cilexetil will be available from Zentiva in four strengths (4mg, 8mg, 16mg and 32mg), indicated for the treatment of essential hypertension in adults, and as an add on therapy to Angiotensin Converting Enzyme (ACE)
- Candesartan from Actavis to 11 European countries on market formation - PharmaLive (press release) (subscription)
- Candesartan from Actavis to 11 European countries on market formationPharmaLive (press release) (subscription)Zug, Switzerland 8 May 2012 - Actavis has launched Candesartan and Candesartan HCT on many of Europe's biggest pharmaceutical markets, immediately after the patents expired
- China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results - MarketWatch (press release)
- China Pharma Holdings, Inc
- Pro Generika zum bevorstehenden Patentablauf von Candesartan: Rabattvertrag ... - ptext.de (Pressemitteilung)
- Pro Generika zum bevorstehenden Patentablauf von Candesartan: Rabattvertrag
- Les IEC réduisent la mortalité totale des hypertendus mais pas les ARA-II - TheHeart.org
- Les IEC réduisent la mortalité totale des hypertendus mais pas les ARA-IITheHeart
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
